Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Trial of Erythropoietin to Prevent Death From Cerebral Impairment During Severe Malaria

NCT00697164 is registered in ClinicalTrials.gov with Claude Bernard University as lead sponsor.

NCT NCT00697164
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00697164 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Trial of Erythropoietin to Prevent Death From Cerebral Impairment During Severe Malaria
Lead sponsor
Claude Bernard University
Phase
Phase 2/3
Overall status
Unknown status
Start date
October 31, 2007
Completion date
March 31, 2009
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral malaria